• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Chamath Palihapitiya's SPAC Track Record Means Double-Digit Losses For You. Here Are The Details On All His Deals

    8/18/22 12:01:45 PM ET
    $BGRY
    $CLOV
    $DM
    $DNAA
    Industrial Machinery/Components
    Industrials
    Medical Specialities
    Health Care
    Get the next $BGRY alert in real time by email

    Chamath Palihapitiya was one of the biggest names in the SPAC market in 2021 and when times were good for new companies going public, Palihapitiya had some of the best-performing deals of that year.

    The year 2022 has not been as kind to Palihapitiya with re-valuations on many of the companies that went public by investors seeing shares below the former $10 price point of the SPACs.

    Here’s an updated look at the performance of the SPAC deals, remaining SPACs and PIPE deals that included Palihapitiya, with returns calculated on the $10 offering price and not factoring in warrants.

    The Palihapitiya SPACs:

    Virgin Galactic Holdings Inc (NYSE:SPCE): Space travel
    Price: $6.88
    Return: -31.2%

    Opendoor Technologies Inc (NASDAQ:OPEN): Online home buying and selling
    Price: $5.20
    Return: -48.0%

    Clover Health Investments (NASDAQ:CLOV): Online health insurance
    Price: $3.20
    Return: -68.0%

    Social Capital Hedosophia Holdings Corp IV (NYSE:IPOD): No target announced
    Price: $9.98
    Return: Flat

    SoFi Technologies Inc (NASDAQ:SOFI): Financial technology
    Price: $7.02
    Return: -29.8%

    Social Capital Hedosophia Holdings Corp VI (NYSE:IPOF): No target announced
    Price: $9.99
    Return: Flat

    Social Capital Suvretta Holdings Corp I (NASDAQ:DNAA): Pending merger with digital medicine company Akili Interactive
    Price: $9.36
    Return: -6.4%

    Social Capital Suvretta Holdings Corp II (NASDAQ:DNAB): No target announced
    Price: $9.76
    Return: -2.4%

    ProKidney Corp (NASDAQ:PROK): Treating chronic kidney diseases
    Price: $7.56
    Return: -24.4%

    Social Capital Suvretta Holdings Corp IV (NASDAQ:DNAD): No target announced
    Price: $9.79
    Return: -2.1%

    Related Link: 5 Things You Might Not Know About Chamath Palihapitiya 

    The PIPE Deals: Along with his own SPACs, Palihapitiya has also been a part of the funding of several SPAC deals as a member of the PIPE (Private Investment in Public Equity). Here’s a look at how these stocks have done since going public.

    Mp Materials (NYSE:MP): Rare earth minerals
    Price: $35.81
    Return: +258.1%

    Desktop Metal Inc (NYSE:DM): 3D printing
    Price: $3.25
    Return: -67.5%

    Metromile Inc: Pay-per-mile insurance company
    Price: Was acquired by Lemonade Inc (NYSE:LMND); Metromile last closing at $1.05
    Return: -89.5%

    Proterra Inc (NASDAQ:PTRA): Electric buses
    Price: $6.57
    Return: -34.3%

    Latch Inc (NASDAQ:LTCH): Enterprise SaaS
    Price: $1.16
    Return: -88.4%

    Sunlight Financial Holdings Inc (NYSE:SUNL): Residential solar financing
    Price: $3.24
    Return: -67.6%

    ReNew Energy Global PLC (NASDAQ:RNW): Renewable energy
    Price: $6.71
    Return: -32.9%

    Berkshire Grey Inc (NASDAQ:BGRY): robotics and automation
    Price: $2.51
    Return: -74.9%

    The Returns: Palihapitiya has been a part of a total of 18 SPAC deals. The list includes 10 of his own SPACs with six having mergers done or pending. Palihapitiya was also involved in eight PIPE deals. The investor may not have a stake in all the companies listed above, but here is a look at how the 18 deals have performed from the $10 price point to Aug. 17, 2022.

    18 Total SPAC deals: -22.7% average

    10 Chamath-led SPACs: -21.2% average

    6 Chamath-led SPACs with deals: -34.6% average

    8 PIPE deals: -17.0%

    What’s Next: Palihapitiya previously had plans to bring SPACs public with tickers IPOA to IPOZ but stopped issuing new SPACs under this ticker scheme at IPOF. The investor issued four biotech SPACs in his most recent offering.

    Two of the biotech SPACs found deals and two are still searching for targets.

    IPOD and IPOF remain two of the largest SPACs seeking target companies. IPOD and IPOF recently filed for an extension vote to extend the deadline by one year from Oct. 14, 2022 to Oct. 14, 2023.

    “While the company is currently evaluating several business combination opportunities, the board of directors of the company has determined that there may not be sufficient time before October 14, 2022, to consummate a business combination,” the filing reads for IPOF.

    The vote will be closely watched to see if a high amount of shares are redeemed at trust value or if shareholders keep their faith in Palihapitiya to deliver strong deals in the future.

    Disclosure: Author is long IPOD, IPOF and MP.

    Photos: Christopher Michel via Flickr Creative Commons

    Get the next $BGRY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BGRY
    $CLOV
    $DM
    $DNAA

    CompanyDatePrice TargetRatingAnalyst
    SoFi Technologies Inc.
    $SOFI
    3/19/2026$19.00Equal Weight
    Wells Fargo
    Lemonade Inc.
    $LMND
    3/17/2026$85.00Equal-Weight → Overweight
    Morgan Stanley
    SoFi Technologies Inc.
    $SOFI
    2/9/2026$30.00Mkt Perform → Mkt Outperform
    Citizens
    SoFi Technologies Inc.
    $SOFI
    2/3/2026$31.00Neutral → Overweight
    Analyst
    SoFi Technologies Inc.
    $SOFI
    2/2/2026$36.00 → $33.00Buy
    Needham
    MP Materials Corp.
    $MP
    1/13/2026Outperform
    William Blair
    SoFi Technologies Inc.
    $SOFI
    1/6/2026$20.50Underperform
    BofA Securities
    Lemonade Inc.
    $LMND
    1/6/2026$98.00Buy
    Truist
    More analyst ratings

    $BGRY
    $CLOV
    $DM
    $DNAA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on SoFi Technologies with a new price target

    Wells Fargo initiated coverage of SoFi Technologies with a rating of Equal Weight and set a new price target of $19.00

    3/19/26 8:27:12 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Lemonade upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Lemonade from Equal-Weight to Overweight and set a new price target of $85.00

    3/17/26 7:54:44 AM ET
    $LMND
    Property-Casualty Insurers
    Finance

    SoFi Technologies upgraded by Citizens with a new price target

    Citizens upgraded SoFi Technologies from Mkt Perform to Mkt Outperform and set a new price target of $30.00

    2/9/26 6:58:53 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $BGRY
    $CLOV
    $DM
    $DNAA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Award-winning Renters Insurance Provider Lemonade Expands U.S. Footprint with Launch of Renters Insurance in South Carolina

    New York, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Lemonade (NYSE:LMND), the tech-first insurance company, today announced the launch of its renters insurance product in South Carolina. The expansion brings Lemonade's digital, customizable coverage to renters statewide, further strengthening the company's presence across the United States. Lemonade Renters is designed to cover the stuff renters love while delivering a best-in-class customer experience. Policies start from $5 per month and are built to be flexible, allowing customers to select coverage amounts and deductibles that fit their lifestyle and budget. Based on the latest industry and Lemonade data, across the U.S., Lemona

    4/2/26 10:00:00 AM ET
    $LMND
    Property-Casualty Insurers
    Finance

    Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026

    WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that Peter Kuipers is stepping down as the Chief Financial Officer of the Company, effective March 30, 2026. Mr. Kuipers will remain with the Company in an advisory capacity through April 24, 2026 to support a smooth transition and handoff. Mr. Kuipers and the Company noted that his departure does not reflect any disagreement with the Company on any matter relating to the Company's operations, policies or practices. The Board of Directors has

    4/1/26 8:30:00 AM ET
    $CLOV
    Medical Specialities
    Health Care

    SoFi Schedules Conference Call to Discuss Q1 2026 Results

    SoFi Technologies, Inc. (NASDAQ:SOFI), the one-stop shop for digital financial services, today announced plans to host a conference call to discuss financial and operating results for the first quarter of 2026 on Wednesday, April 29, 2026, at 8 a.m. Eastern Time. SoFi also plans to release its first quarter 2026 results on the investor relations section of its website at https://investors.sofi.com at approximately 7 a.m. Eastern Time on Wednesday, April 29, 2026. Full session details for the conference call and webcast are as follows: CONFERENCE CALL DETAILS – TO DIAL IN BY PHONE To pre-register for this call, please go to the following link (you will then receive your personal dial-in

    4/1/26 8:00:00 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $BGRY
    $CLOV
    $DM
    $DNAA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Priest Brady Patrick

    4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)

    4/3/26 4:59:27 PM ET
    $CLOV
    Medical Specialities
    Health Care

    SEC Form 4 filed by Reynoso Jamie L.

    4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)

    4/3/26 4:34:43 PM ET
    $CLOV
    Medical Specialities
    Health Care

    SEC Form 4 filed by Toy Andrew

    4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)

    4/3/26 4:31:15 PM ET
    $CLOV
    Medical Specialities
    Health Care

    $BGRY
    $CLOV
    $DM
    $DNAA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Noto Anthony bought $500,516 worth of shares (28,900 units at $17.32), increasing direct ownership by 0.25% to 11,704,352 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/17/26 4:05:47 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Chief Executive Officer Noto Anthony bought $1,001,515 worth of shares (56,000 units at $17.88), increasing direct ownership by 0.48% to 11,675,452 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/2/26 3:36:37 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    General Counsel Lavet Robert S bought $105,220 worth of shares (5,000 units at $21.04) (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/6/26 6:18:51 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $BGRY
    $CLOV
    $DM
    $DNAA
    SEC Filings

    View All

    SEC Form 6-K filed by ReNew Energy Global plc

    6-K - ReNew Energy Global plc (0001848763) (Filer)

    4/2/26 4:30:02 PM ET
    $RNW
    Electric Utilities: Central
    Utilities

    SEC Form S-8 filed by Virgin Galactic Holdings Inc.

    S-8 - Virgin Galactic Holdings, Inc (0001706946) (Filer)

    4/1/26 4:32:06 PM ET
    $SPCE
    Transportation Services
    Consumer Discretionary

    Clover Health Investments Corp. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

    4/1/26 8:32:45 AM ET
    $CLOV
    Medical Specialities
    Health Care

    $BGRY
    $CLOV
    $DM
    $DNAA
    Leadership Updates

    Live Leadership Updates

    View All

    Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026

    WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that Peter Kuipers is stepping down as the Chief Financial Officer of the Company, effective March 30, 2026. Mr. Kuipers will remain with the Company in an advisory capacity through April 24, 2026 to support a smooth transition and handoff. Mr. Kuipers and the Company noted that his departure does not reflect any disagreement with the Company on any matter relating to the Company's operations, policies or practices. The Board of Directors has

    4/1/26 8:30:00 AM ET
    $CLOV
    Medical Specialities
    Health Care

    Critical Minerals Boom: Nickel–Cobalt Market Races Toward $35B+ Valuation

    NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Nickel–cobalt alloys might not sound exciting at first, but they're actually a big deal in modern defense. These materials are used in things like jet engines, missile systems, and naval equipment because they can handle extreme heat and stress without breaking down. That's why governments are starting to treat nickel and cobalt as must-have resources, not just commodities. There's also a growing push to secure supply closer to home, since a lot of global production is concentrated in a few regions—something that makes defense planners (and investors) a bit uneasy.   Active Companies mentioned in the article

    3/31/26 8:45:00 AM ET
    $ALOY
    $MP
    $TMC
    Metal Mining
    Basic Materials

    ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer

    WINSTON-SALEM, N.C., March 25, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today announced the appointment of Greg Madison as Chief Commercial Officer. In this role, Mr. Madison will drive ProKidney's commercial strategy as the Company advances towards the potential commercialization of rilparencel. "Greg is a seasoned commercial biopharma executive with a proven track record of building high-performing organizations, shaping strategy, and preparing innovative therapies for market," said Bruce Culleton, M.D., CEO of ProKidney. "He brings valuable operation

    3/25/26 4:01:00 PM ET
    $PROK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BGRY
    $CLOV
    $DM
    $DNAA
    Financials

    Live finance-specific insights

    View All

    SoFi Schedules Conference Call to Discuss Q1 2026 Results

    SoFi Technologies, Inc. (NASDAQ:SOFI), the one-stop shop for digital financial services, today announced plans to host a conference call to discuss financial and operating results for the first quarter of 2026 on Wednesday, April 29, 2026, at 8 a.m. Eastern Time. SoFi also plans to release its first quarter 2026 results on the investor relations section of its website at https://investors.sofi.com at approximately 7 a.m. Eastern Time on Wednesday, April 29, 2026. Full session details for the conference call and webcast are as follows: CONFERENCE CALL DETAILS – TO DIAL IN BY PHONE To pre-register for this call, please go to the following link (you will then receive your personal dial-in

    4/1/26 8:00:00 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Virgin Galactic Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    Sales Open for Virgin Galactic Spaceflight Expeditions - Priced At $750K First of Two New SpaceShips Progressing to Ground Test Phase in April; Flight Test Phase Begins Q3 2026 Commercial Spaceflight Operations with First New SpaceShip Continue on Track for Q4 2026 Second New SpaceShip Expected to Enter Service Between Late Q4 2026 and Early Q1 2027 Virgin Galactic Holdings, Inc. (NYSE:SPCE) ("Virgin Galactic" or the "Company") today announced its financial results for the fourth quarter and full year ended December 31, 2025 and provided a business update. CEO Michael Colglazier said, "We completed pivotal milestones during the first quarter of 2026, and with assembly of our

    3/30/26 4:05:00 PM ET
    $SPCE
    Transportation Services
    Consumer Discretionary

    Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance

    Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-yearAchieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retentionExpect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full year 2025 Medicare Advantage membership of 113,803, up 38% year-over-yearFull year 2025 Total revenues of $1.9 billion, up 40% year-over-yearFull year 2025 GAAP Net loss of $86 million, Adjusted EBITDA of $22 million, and Adjusted Net Income of $20 million Full Year 2026 Gu

    2/26/26 4:05:00 PM ET
    $CLOV
    Medical Specialities
    Health Care

    $BGRY
    $CLOV
    $DM
    $DNAA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Latch Inc.

    SC 13G - Latch, Inc. (0001826000) (Subject)

    12/13/24 9:45:09 PM ET
    $LTCH
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by ReNew Energy Global plc

    SC 13D/A - ReNew Energy Global plc (0001848763) (Subject)

    12/10/24 7:57:27 PM ET
    $RNW
    Electric Utilities: Central
    Utilities

    Amendment: SEC Form SC 13D/A filed by ReNew Energy Global plc

    SC 13D/A - ReNew Energy Global plc (0001848763) (Subject)

    12/10/24 7:53:40 PM ET
    $RNW
    Electric Utilities: Central
    Utilities

    $BGRY
    $CLOV
    $DM
    $DNAA
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care